Colorectal (bowel) cancer is a major global health challenge that can be monitored and managed through genetic screening and targeted therapies.
Which of the following is a characteristic of malignant tumour cells compared to benign tumour cells?
Some colorectal cancers are stimulated to grow when epidermal growth factor (EGF) binds to specific receptor proteins on their cell membranes. Explain why treating patients with monoclonal antibodies designed to block these EGF receptors can be an effective therapy.
Cells usually become cancerous due to mutations in genes regulating the cell cycle. Scientists have identified the APC gene, which normally acts as a tumour suppressor to prevent uncontrolled cell division.
In a population of 36 400 00036\ 400\ 00036 400 000 individuals, 111 in 650650650 carries a pathogenic mutation in their APC gene.
Genetic screening allows individuals to discover if they carry the mutated APC gene. Carriers are often offered a prophylactic total colectomy (surgical removal of the entire large intestine) before cancer develops. Suggest two reasons why deciding to undergo this procedure can be extremely difficult for a carrier of this mutation.